Cellevate
Last verified 2026-05-02. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $7.1Mattributed |
|---|---|
| Latest round | grant, $2.7M, 2026-04-01attributed |
| Founded | 2014 |
| Headquarters | Lund, Sweden |
| Industry | biotech |
| Stage | seed |
| Website | cellevate.com |
Cellevate makes nanofiber-based cell culture products for upstream bioprocessing, branded Cellevat3d, used in cell therapy, gene therapy, and vaccine production. It serves CDMOs and biopharma companies scaling viral vector and cell-therapy manufacturing. Its cellulose-based nanofiber microcarriers report over 10x higher yields in viral vaccine production than conventional microcarriers.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-04-01 | grant | $2.7M | undisclosed |
Detected tech stack
Nginx, WordPress 6.9.4, Yoast SEO 27.6, Kadence WP Kadence 1.5.0, Google Tag Manager, Gravity Forms 2.10.1, jQuery Migrate 3.4.1, PHP, ZURB Foundation, WooCommerce, WordPress Block Editor, Python
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $2.7M | attributed | eu-grant named as publisher. No document URL on file. |
| Total raised $7.1M | attributed | eu-grant named as publisher. No document URL on file. |
| Company existence | self-reported | cellevate.com, read 2026-05-02 |
| Description | self-reported | cellevate.com, read 2026-05-02 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.